Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Fresenius Medical Care AG (FMS) over the last 8 years, with Q3 2025 value amounting to $418.4 million.

  • Fresenius Medical Care AG's Depreciation & Amortization (CF) rose 436.62% to $418.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 343.8%. This contributed to the annual value of $1.9 billion for FY2024, which is 119.28% down from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Depreciation & Amortization (CF) is $418.4 million, which was up 436.62% from $425.6 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Depreciation & Amortization (CF) ranged from a high of $556.2 million in Q1 2024 and a low of $400.9 million during Q3 2024
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $470.2 million (2022), whereas its average is $467.8 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Depreciation & Amortization (CF) tumbled by 2783.3% in 2021, and later skyrocketed by 1831.3% in 2024.
  • Fresenius Medical Care AG's Depreciation & Amortization (CF) (Quarter) stood at $499.9 million in 2021, then rose by 1.02% to $505.0 million in 2022, then decreased by 9.24% to $458.4 million in 2023, then increased by 11.21% to $509.7 million in 2024, then decreased by 17.93% to $418.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $418.4 million in Q3 2025, compared to $425.6 million in Q2 2025 and $415.5 million in Q1 2025.